Nodus Oncology’s Acquisition of IP Assets From Basilea Pharmaceutica International AG

Burges Salmon advised biotech company Nodus Oncology on the deal.Nodus Oncology, a novel biotech company, on its strategic acquisition of certain oncology based IP assets from…